Demographic and medication characteristics of traditional Chinese medicine users among colorectal cancer survivors: A nationwide database study in Taiwan

10.1016/j.jtcme.2016.07.001

Chien-Tung Wu；Yueh-Ting Tsai；Jung-Nien Lai

Colorectal cancer ； Traditional Chinese medicine ； National health insurance research database ； Chinese herbal product ； Costusroot and Amomum Six Gentlemen ； Decoction

Journal of Traditional and Complementary Medicine

7卷2期（2017 / 04 / 01）

188 - 194

英文

Chinese herbal product (CHP) is the major type of traditional Chinese medicine (TCM) and widely used to relief the symptom of colorectal cancer. The aim of the study was to analyze the utilization of CHP for treating patients with colorectal cancer in Taiwan. The usage of CHP, frequency of services, and prescription pattern for colorectal cancer were analyzed from a randomly sampled cohort of 1 million beneficiaries from the National Health Insurance Research Database. The odds ratios for utilization of CHP were estimated with logistic regression model. 2846 patients were newly diagnosed as colorectal cancer during 1998-2008 in the million cohort in Taiwan. 42.7% (n=1214) of them used CHP. Colorectal cancer was the most common diagnosis coded by TCM doctor, followed by symptoms, signs, and ill-defined conditions. Costusroot and Amomum Six Gentlemen Decoction (香砂六君子湯xiāng shā liù jūn zĭ tāng) was the most frequently prescribed formula for treating colorectal cancer. Among the top 10 most frequently prescribed CHP for treating colorectal cancer, six containing Ginseng Radix (人參, Panax ginseng) and two containing Astragali Radix (黃耆, Astragalus membranaceus), which are reported to have potential beneficial synergistic effects on colorectal cancer cells. CHP containing Ginseng Radix or Astragali Radix are the most frequently prescribed for colorectal cancer and their effects should be taken into account by healthcare providers.

1. Centers for Disease Control and Prevention. International classification of diseases, ninth revision, clinical modification (ICD-9-CM). http://www.cdc.gov/nchs/icd/icd9cm.htm. Published 2014. Accessed February 21, 2016.
2. Astin, JA,Pelletier, KR,Marie, A,Haskell, WL(2000).Complementary and alternative medicine use among elderly persons: one-year analysis of a Blue Shield Medicare supplement.J Gerontol A Biol Sci Med Sci.,55,M4-M9.
3. August, DA,Ottow, RT,Sugarbaker, PH(1984).Clinical perspective of human colorectal cancer metastasis.Cancer Metastasis Rev,3,303-324.
4. Barnes, PM,Powell-Griner, E,McFann, K,Nahin, RL(2004).Complementary and alternative medicine use among adults: United States, 2002.Adv Data,343,1-19.
5. Boon, HS,Olatunde, F,Zick, SM(2007).Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005.BMC Womens Health,7,4.
6. Boyle, P,Leon, ME(2002).Epidemiology of colorectal cancer.Br Med Bull,64,1-25.
7. Burstein, HJ,Gelber, S,Guadagnoli, E,Weeks, JC(1999).Use of alternative medicine by women with early-stage breast cancer.N Engl J Med.,340,1733-1739.
8. Eisenberg, DM,Davis, RB,Ettner, SL(1998).Trends in alternative medicine use in the United States, 1990-1997.JAMA J Am Med Assoc,280,1569-1575.
9. Eisenberg, DM,Kessler, RC,Foster, C,Norlock, FE,Calkins, DR,Delbanco, TL(1993).Unconventional medicine in the United States. Prevalence, costs, and patterns of use.N Engl J Med.,328,246-252.
10. Fang, RC,Tsai, YT,Lai, JN,Yeh, CH,Wu, CT(2012).The traditional chinese medicine prescription pattern of endometriosis patients in Taiwan: a population-based study.Evid Based Complement Altern Med,2012,591391.
11. Haggar, FA,Boushey, RP(2009).Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors.Clin Colon Rectal Surg,22,191-197.
12. Huang, CY,Tsai, YT,Lai, JN,Hsu, FL(2013).Prescription pattern of Chinese herbal products for diabetes mellitus in Taiwan: a population-based study.Evid Based Complement Altern Med,2013
13. Humpel, N,Jones, SC(2006).Gaining insight into the what, why and where of complementary and alternative medicine use by cancer patients and survivors.Eur J Cancer Care,15,362-368.
14. Institutes NHR(2015).Institutes NHR. National Health Insurance Research database. http://nhird.nhri.org.tw/en/index.html. Published 2015. Accessed February 21, 2016..http://nhird.nhri.org.tw/en/index.html
15. Kang, KA,Kim, HS,Kim, DH,Hyun, JW(2013).The role of a ginseng saponin metabolite as a DNA methyltransferase inhibitor in colorectal cancer cells.Int J Oncol.,43,228-236.
16. Kummar, S,Sitki Copur, M,Rose, M(2011).A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer.Clin Colorectal Cancer,10,85-96.
17. Lai, J-N,Wu, C-T,Wang, J-D(2012).Prescription pattern of chinese herbal products for breast cancer in taiwan: a population-based study.Evid Based Complement Altern Med,2012,891893.
18. Law, PC,Auyeung, KK,Chan, LY,Ko, JK(2012).Astragalus saponins downregulate vascular endothelial growth factor under cobalt chloride-stimulated hypoxia in colon cancer cells.BMC Complement Altern Med,12,160.
19. Lawsin, C,DuHamel, K,Itzkowitz, SH(2007).Demographic, medical, and psychosocial correlates to CAM use among survivors of colorectal cancer.Support Care Cancer,15,557-564.
20. Lee, YC,Huang, YT,Tsai, YW(2010).The impact of universal National Health Insurance on population health: the experience of Taiwan.BMC Health Serv Res,10,225.
21. Ministry of Health and Welfare. List of unified formulas. http://www.mohw.gov.tw/CHT/DOCMAP/DM1.aspx?f_list_no=758&fod_list_no=3918. Published 2013. Accessed February 21, 2016.
22. Ritvo, P,Irvine, J,Katz, J,Matthew, A,Sacamano, J,Shaw, BF(1999).The patient's motivation in seeking complementary therapies.Patient Educ Couns,38,161-165.
23. Shi, S,Klotz, U(2012).Drug interactions with herbal medicines.Clin Pharmacokinet,51,77-104.
24. Stein, KD,Kaw, C,Crammer, C,Gansler, T(2009).The role of psychological functioning in the use of complementary and alternative methods among disease-free colorectal cancer survivors.Cancer,115,4397-4408.
25. Su, SY,Huang, JY,Jian, ZH,Ho, CC,Lung, CC,Liaw, YP(2012).Mortality of colorectal cancer in Taiwan, 1971-2010: temporal changes and age-period-cohort analysis.Int J Colorectal Dis.,27,1665-1672.
26. US Burden of Disease Collaborators(2013).The state of US health, 1990-2010: burden of diseases, injuries, and risk factors.JAMA,310,591-608.
27. Wolsko, PM,Eisenberg, DM,Davis, RB,Ettner, SL,Phillips, RS(2002).Insurance coverage, medical conditions, and visits to alternative medicine providers.Arch Intern Med,162,281.
28. Yang, YH,Chen, PC,Wang, JD,Lee, CH,Lai, JN(2009).Prescription pattern of traditional Chinese medicine for climacteric women in Taiwan.Climacteric,12,541-547.

1. Alinafe Magret Kapelemera(2017)。汰癌勝與香砂六君子湯併用之藥物動力學之研究。臺北醫學大學藥學系(碩博士班)學位論文。2017。1-62。